ASPYRE a novel genomic assay (IMAGE)
Caption
Biofidelity CMO Dr. Wendy Levin says the company has developed a novel genomic assay that can analyze DNA and RNA concurrently for NSCLC.
Credit
Biofidelity
Usage Restrictions
N/A
License
Original content